Zacks Research Has Pessimistic Outlook of Amdocs Q2 Earnings

Amdocs Limited (NASDAQ:DOX) – Equities research analysts at Zacks Research decreased their Q2 2026 earnings per share estimates for Amdocs in a research report issued to clients and investors on Tuesday, February 24th. Zacks Research analyst Team now expects that the technology company will post earnings of $1.50 per share for the quarter, down from their prior estimate of $1.60. The consensus estimate for Amdocs’ current full-year earnings is $6.21 per share. Zacks Research also issued estimates for Amdocs’ Q3 2026 earnings at $1.68 EPS, Q4 2026 earnings at $1.77 EPS, FY2026 earnings at $6.56 EPS, Q1 2027 earnings at $1.69 EPS, Q2 2027 earnings at $1.73 EPS, Q3 2027 earnings at $1.79 EPS, Q4 2027 earnings at $1.83 EPS and FY2027 earnings at $7.04 EPS.

Several other brokerages have also recently weighed in on DOX. Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Stifel Nicolaus dropped their target price on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Bank of America reduced their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Finally, Barclays dropped their price objective on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Amdocs Trading Down 0.1%

NASDAQ DOX opened at $69.80 on Friday. Amdocs has a one year low of $65.74 and a one year high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market capitalization of $7.53 billion, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 1.24 and a beta of 0.40. The company’s 50-day simple moving average is $77.63 and its two-hundred day simple moving average is $80.57.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same period last year, the business posted $1.66 EPS. Amdocs’s quarterly revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in DOX. Pzena Investment Management LLC grew its holdings in shares of Amdocs by 82.6% during the fourth quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock valued at $969,100,000 after buying an additional 5,443,766 shares during the last quarter. LSV Asset Management lifted its position in Amdocs by 0.8% during the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock worth $296,159,000 after acquiring an additional 29,829 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Amdocs by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock valued at $253,786,000 after purchasing an additional 54,676 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Amdocs by 3.0% in the third quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after purchasing an additional 91,900 shares during the period. Finally, Vanguard Group Inc. raised its stake in shares of Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after purchasing an additional 9,207 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 annualized dividend and a yield of 3.3%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s payout ratio is presently 40.81%.

More Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs announced a multi‑year strategic collaboration with Amazon Web Services to combine Amdocs’ aOS agentic operating system with AWS AI and cloud capabilities to drive telecom modernization — a material commercial & product endorsement that supports future revenue growth. MWC 2026: Amdocs and AWS Announce Multi-Year Strategic Collaboration to Accelerate AI-Driven Telecom Modernization
• Positive Sentiment: Amdocs announced a collaboration with Microsoft to deliver AI‑accelerated application modernization (Amdocs Agentic Services + Microsoft AI), which can expand enterprise services and upsell opportunities. MWC 2026: Amdocs Collaborates with Microsoft to Bring AI-Accelerated Application Modernization to Enterprises
• Positive Sentiment: Amdocs partnered with Google Cloud to combine Gemini Enterprise CX with Amdocs’ Cognitive Core to create an agentic telco contact center — another strategic cloud/A.I. endorsement that could help win telco transformation deals. MWC 2026: Amdocs Collaborates with Google Cloud to Accelerate AI Adoption and Power the Agentic Telco Contact Center
• Positive Sentiment: Zacks Research raised multiple near‑ and medium‑term EPS forecasts (including FY2026/FY2027/FY2028 upgrades and several quarterly raises), which supports a more constructive earnings outlook and could underpin valuation. See Zacks coverage for context. Amdocs (DOX) is a Top-Ranked Growth Stock: Should You Buy?
• Neutral Sentiment: Published short‑interest notices show zero reported short interest and anomalous “NaN” increases across several February reporting dates — this appears to be a data/reporting issue and implies no visible short‑squeeze pressure at present.
• Negative Sentiment: Zacks trimmed its Q2 2026 EPS estimate from $1.60 to $1.50 in the same round of updates — a modest near‑term earnings downgrade that could temper sentiment around the next quarter.
• Negative Sentiment: Technically, the share price is below both the 50‑day and 200‑day moving averages noted in recent quotes, which can invite short‑term selling/ profit‑taking even amid positive fundamental headlines.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.